C.J.P. Webers

Currently working as an assistant professor in musculoskeletal epidemiology, focusing on chronic (inflammatory and non-inflammatory) musculoskeletal disease. Specific areas of interest: perspective on health and disease, treatment goals, phenotyping, context, personal and societal consequences of disease.

Other areas of research interest: health-economic analysis, work participation outcomes, research methodology.

Selection of current projects:

• Patient and physician perspectives on health and disease: multi-stage project (in development) in which both existing data and newly collected data are used to better understand why patients with chronic musculoskeletal diseases and their physicians can differ in their assessment of disease state (discrepancy), and whether such discrepancies have impact on patient and societal outcomes. Part of long-term research line on improving care for chronic musculoskeletal disease in daily practice.
• Several project in inflammatory musculoskeletal disorders (in particular spondyloarthritis), focusing on residual disease (definition, prevalence, associated factors, prognosis, phenotypes), discrepancies between disease activity and patient-reported health, and early remission-induction strategies

• Webers, C., El-Din, R. N., Beckers, E., Been, M., Vonkeman, H. E., & van Tubergen, A. (2025). Factors associated with treatment intensification in patients with axial spondyloarthritis and high disease activity in clinical practice. Rheumatology, 64(1), 91-98. Article kead634. https://doi.org/10.1093/rheumatology/kead634

  More information about this publication
• Webers, C., Boonen, A., Vonkeman, H. E., & van Tubergen, A. (2023). Factors Associated With Residual Disease in Axial Spondyloarthritis: Results From a Clinical Practice Registry. Journal of Rheumatology, 50(11), 1430-1438. https://doi.org/10.3899/jrheum.2023-0194

  More information about this publication
• Webers, C., Grimm, S., van Tubergen, A., van Gaalen, F., van der Heijde, D., Joore, M., & Boonen, A. (2023). The value of correctly diagnosing axial spondyloarthritis for patients and society. Seminars in Arthritis and Rheumatism, 62(1), Article 152242. https://doi.org/10.1016/j.semarthrit.2023.152242

  More information about this publication
• Webers, C., Kiltz, U., Braun, J., van der Heijde, D., & Boonen, A. (2023). The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter? Rheumatology, 62(6), 2139-2146. https://doi.org/10.1093/rheumatology/keac580

  More information about this publication
• Butink, M. H. P., Webers, C., Verstappen, S. M. M., Falzon, L., Betteridge, N., Wiek, D., Woolf, A. D., Stamm, T. A., Burmester, G. R., Bijlsma, J. W. J., Christensen, R., & Boonen, A. (2023). Non-pharmacological interventions to promote work participation in people with rheumatic and musculoskeletal diseases: a systematic review and meta-analysis from the EULAR taskforce on healthy and sustainable work participation. RMD Open, 9(1), Article e002903. https://doi.org/10.1136/rmdopen-2022-002903

  More information about this publication
• Boonen, A., Webers, C., Butink, M., Barten, B., Betteridge, N., Black, D. C., Bremander, A., Boteva, B., Brzezińska, O., Chauhan, L., Copsey, S., Guimarães, V., Gignac, M., Glaysher, J., Green, F., Hoving, J. L., Marques, M. L., Smucrova, H., Stamm, T. A., ... Verstappen, S. M. M. (2023). 2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work. Annals of the Rheumatic Diseases, 82(1), 57-64. https://doi.org/10.1136/ard-2022-222678

  More information about this publication
• Ramiro, S., Nikiphorou, E., Sepriano, A., Ortolan, A., Webers, C., Baraliakos, X., Landewé, R. B. M., Van den Bosch, F. E., Boteva, B., Bremander, A., Carron, P., Ciurea, A., van Gaalen, F. A., Géher, P., Gensler, L., Hermann, J., de Hooge, M., Husakova, M., Kiltz, U., ... van der Heijde, D. (2023). ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Annals of the Rheumatic Diseases, 82(1), 19-34. https://doi.org/10.1136/ard-2022-223296

  More information about this publication
• Webers, C., Ortolan, A., Sepriano, A., Falzon, L., Baraliakos, X., Landewé, R. B. M., Ramiro, S., van der Heijde, D., & Nikiphorou, E. (2023). Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis. Annals of the Rheumatic Diseases, 82(1), 130-141. https://doi.org/10.1136/ard-2022-223298

  More information about this publication
• Ortolan, A., Webers, C., Sepriano, A., Falzon, L., Baraliakos, X., Landewé, R. B., Ramiro, S., van der Heijde, D., & Nikiphorou, E. (2023). Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. Annals of the Rheumatic Diseases, 82(1), 142-152. https://doi.org/10.1136/ard-2022-223297

  More information about this publication
• Molto, A., Lopez-Medina, C., Van den Bosch, F. E., Boonen, A., Webers, C., Dernis, E., van Gaalen, F. A., Soubrier, M., Claudepierre, P., Baillet, A., Starmans-Kool, M., Spoorenberg, A., Jacques, P., Carron, P., Joos, R., Lenaerts, J., Gossec, L., Pouplin, S., Ruyssen-Witrand, A., ... Dougados, M. (2021). Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial. Annals of the Rheumatic Diseases, 80(11), 1436-1444. https://doi.org/10.1136/annrheumdis-2020-219585

  More information about this publication